Société PHAXIAM Therapeutics S.A. Euronext Paris
Actions
PHXM
FR0011471135
Recherche biotechnologique et médicale
Temps réel
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
2,965 EUR | +2,42 % | +0,85 % | -35,54 % |
Métier
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Thibaut du Fayet
CEO | Chief Executive Officer | 56 | 23/06/23 |
Eric Soyer
DFI | Director of Finance/CFO | 57 | 23/06/23 |
Pascal Birman
CTO | Chief Tech/Sci/R&D Officer | - | 23/06/23 |
Cindy Fevre
CTO | Chief Tech/Sci/R&D Officer | - | 23/06/23 |
Céline Breda
CTO | Chief Tech/Sci/R&D Officer | 54 | 23/06/23 |
Karine Charton
PRN | Corporate Officer/Principal | - | 23/06/23 |
General Counsel | - | 23/06/23 | |
Human Resources Officer | - | 23/06/23 | |
Jérôme Bailly
PRN | Corporate Officer/Principal | 45 | 23/06/23 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Director/Board Member | 63 | 23/06/23 | |
Hilde Windels
BRD | Director/Board Member | 59 | 23/06/23 |
Gil Beyen
BRD | Director/Board Member | 62 | 23/06/23 |
Martine George
BRD | Director/Board Member | 76 | 23/06/23 |
Director/Board Member | 66 | 23/06/23 | |
Didier Hoch
CHM | Chairman | 68 | 23/06/23 |
Leila Nicolas
BRD | Director/Board Member | - | 23/06/23 |
Robert Sebbag
BRD | Director/Board Member | 73 | 23/06/23 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 3 101 855 | 3 053 989 ( 98,46 %) | 250 ( 0,008060 %) | 98,46 % |
Participations
Nom | Actions | % | Valorisation |
---|---|---|---|
250 | 0,00% | 821 $ |
Coordonnées société
Secteur
Ventes par région
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
+1,10 % | 106 Md | |
+9,29 % | 103 Md | |
-2,88 % | 21,44 Md | |
-11,89 % | 22,11 Md | |
-26,59 % | 20,99 Md | |
-6,64 % | 19,44 Md | |
-6,58 % | 17,6 Md | |
+5,83 % | 13,88 Md | |
+7,46 % | 11,75 Md |
- Bourse
- Actions
- Action PHAXIAM Therapeutics S.A.
- Action PHAXIAM Therapeutics S.A. - Euronext Paris
- Société PHAXIAM Therapeutics S.A.